Filter
1715
Filtered Results: 1715
Text search:
Pan
American
Health
Organisation
Featured
Recommendations
179
New Publications
297
Language
Document type
No document type
608
Studies & Reports
357
Guidelines
342
Manuals
126
Strategic & Response Plan
74
Fact sheets
72
Training Material
43
Situation Updates
25
Infographics
23
Resource Platforms
20
Brochures
10
Videos
8
Dashboards/Maps
4
Online Courses
3
Countries / Regions
Latin America and the Carribbean
241
Brazil
105
Global
101
Colombia
45
Paraguay
39
Venezuela
34
Mozambique
29
Haiti
28
Angola
25
Argentina
23
Africa
23
India
17
Peru
15
North America
15
Guinea-Bissau
13
Bolivia
13
Ecuador
11
Syria
10
Western and Central Europe
10
Kenya
9
Myanmar / Burma
9
Chile
9
Russia
9
Nigeria
8
Middle East and North Africa
8
Ethiopia
7
Philippines
7
Nepal
7
West and Central Africa
7
Asia
7
Liberia
6
South Africa
6
Ukraine
6
Yemen
6
Eastern Europe
6
Ghana
5
Uganda
5
South Sudan
5
Tanzania
5
Bangladesh
5
Mexico
5
East and Southern Africa
5
Zambia
4
Cambodia
4
Indonesia
4
Eswatini/ Swaziland
4
Burkina Faso
3
Sierra Leone
3
Congo, Democratic Republic of
3
Pakistan
3
Malawi
3
Honduras
3
El Salvador
3
Guatemala
3
South–East Asia Region
3
Iran
3
Uruguay
3
Spain
3
Zimbabwe
2
China
2
Rwanda
2
Papua New Guinea
2
Sudan
2
Dominican Republic
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Moldova
2
Jamaica
2
Portugal
2
Guinea
1
Mali
1
Morocco
1
Saudi Arabia
1
Somalia
1
Iraq
1
Jordan
1
Germany
1
Lebanon
1
Thailand
1
Benin
1
Central African Republic
1
Namibia
1
Cuba
1
Botswana
1
Greece
1
Libya
1
Lesotho
1
Bahamas
1
Nicaragua
1
Fiji
1
Italy
1
Albania
1
Laos
1
Tajikistan
1
Estonia
1
Kyrgyzstan
1
Georgia
1
Vietnam
1
Japan
1
France
1
Tunisia
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
517
Clinical Guidelines
192
Public Health
118
Women & Child Health
103
Key Resources
87
Capacity Building
30
Pharmacy & Technologies
29
Annual Report MEDBOX
1
Toolboxes
COVID-19
353
Mental Health
150
HIV
97
Rapid Response
92
TB
89
NTDs
87
Planetary Health
78
Zika
69
Caregiver
53
NCDs
53
AMR
40
Global Health Education
35
Disability
32
Natural Hazards
32
Pharmacy
25
Conflict
21
Ebola
20
Cholera
19
Refugee
17
Health Financing Toolbox
15
Specific Hazards
7
Polio
6
Typhoon
2
Social Ethics
1
Bulletin of the World Health Organization; http://dx.doi.org/10.2471/BLT.16.176677
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public ... specialists, clinicians and other relevant stakeholders, in order to strengthen public health preparedness for radiation emergencies in WHO Member States as required by the International Health Regulations (IHR) and in line with the international safety standards (GSR Part 7). The scope of the guidelines is confined to public health aspects of planning and implementation of ITB before and during a radiation emergency, such as dosage and timing of ITB administration, adverse effects of stable iodine, its packaging, storage, and distribution.
These guidelines supersede the 1999 WHO Guidelines for Iodine Prophylaxis following Nuclear Accidents.
This ten year global plan for measles and rubella outlines the strategy that needs to be fully implemented to achieve the measles and rubella goals endorsed by the World Health Assembly. The plan sets out the: vision, goals and targets for the 2011-...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting f...
Updated 20 Nov. 2020
Countries can use this checklist of hospital governance, structures, plans and protocols to rapidly determine the current capacities of hospitals to respond to the COVID-19 pandemic and to identify gaps and major areas that require investment and action for the development of h...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Priority medical devices list for the COVID-19 response and associated technical specifications
recommended
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
COVID-19 has heavily emphasized how contact tracing is crucial for managing outbreaks, and as part of the strategy for adjusting, and eventually lifting, lockdowns and other stringent public health and social measures. As the pandemic develops furth...
: interim guidance, 17 February 2021
This document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19). It emphasizes the importance of being prepared and responding quickly and outlines key actions and measures that...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo...
The recently published World Health Organization (WHO) Strengthening infection prevention and control in primary care document collates existing standards, measurement and implementation approaches,...
Understanding and addressing violence against women
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World ... Organization (WHO) call to action by putting into place best-practice TFA policies. Mandatory TFA policies are currently in effect for 3.4 billion people in 60 countries (43% of the world population); of these, 43 countries have best-practice policies in effect, covering 2.8 billion people (36% of the world population).
Over the past year, several additional countries took action to eliminate industrially produced TFA: best-practice policies came into effect in India in January 2022, Uruguay in May 2022 and Oman in July 2022. Best-practice policies were passed in Bangladesh in November 2021 (to come into effect in December 2022) and in Ukraine in September 2020 (to come into effect in October 2023), best-practice TFA policies are projected to pass soon in Mexico, Nigeria and Sri Lanka.
